Uncontrolled asthma in a commercially insured population from 2002 to 2007: Trends, predictors, and costs

Journal of Asthma

Volumn 47, Issue 5, 2010, Pages 574-580

  Sawicki, Gregory S ^a   Vilk, Yury ^b   Schatz, Michael ^c   Kleinman, Ken ^b   Abrams, Allyson ^b   Madden, Jeanne ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Health care utilization; Health services research; Uncontrolled asthma

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG; STEROID;

ADOLESCENT; ADULT; AGE; ARTICLE; ASTHMA; CHILD; COST CONTROL; DISEASE CONTROL; DRUG USE; EDUCATIONAL STATUS; EMERGENCY CARE; FEMALE; FREQUENCY ANALYSIS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; PREDICTION; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG COSTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; FORECASTING; HEALTH CARE COSTS; HEALTH SERVICES; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; MALE; MASSACHUSETTS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; YOUNG ADULT;

EID: 77953859339     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770901003792841     Document Type: Article

References (32)

1. Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, Scalia MR, Akinbami LJ. National surveillance for asthma-United States, 1980-2004. MMWR Surveill Summ 2007; 56:1-54.
2. Gendo K, Sullivan SD, Lozano P, Finkelstein JA, Fuhlbrigge A,Weiss KB. Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol 2003; 91:251-257.
3. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156(3 Pt 1):787-793.
4. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, Fitzgerald JM. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009; 9:24.
5. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007; 120(5 Suppl):S94-S138.
6. Cloutier MM, Wakefield DB, Sangeloty-Higgins P, Delaronde S, Hall CB. Asthma guideline use by pediatricians in private practices and asthma morbidity. Pediatrics 2006; 118:1880-1887.
7. Cloutier MM, Hall CB, Wakefield DB, Bailit H. Use of asthma guidelines by primary care providers to reduce hospitalizations and emergency department visits in poor, minority, urban children. J Pediatr 2005; 146: 591-597.
8. Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117:549-556.
9. Peters D, Chen C, Markson LE, Allen-Ramey FC, Vollmer WM. Using an asthma control questionnaire and administrative data to predict health-care utilization. Chest 2006; 129:918-924.
10. Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med 2006; 100:1139-1151.
11. Schatz M, Zeiger RS, Vollmer WM, Mosen D, Apter AJ, Stibolt TB, Leong A, Johnson MS, Mendoza G, Cook EF. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 2006; 117:995-1000.
12. Carlton BG, Lucas DO, Ellis EF, Conboy-Ellis K, Shoheiber O, Stempel DA. The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. J Asthma 2005; 42:529-535.
13. Schatz M, Zeiger RS, Vollmer WM,Mosen D, Apter AJ, Stibolt TB, Leong A, Johnson MS, Mendoza G, Cook EF. Development and validation of a medication intensity scale derived from computerized pharmacy data that predicts emergency hospital utilization for persistent asthma. Am J Manag Care 2006; 12:478-484.
14. Bennett AV, Lozano P, Richardson LP,McCauley E, KatonWJ. Identifying high-risk asthma with utilization data: a revised HEDIS definition. Am J Manag Care 2008; 14:450-456.
15. Lieu TA, Quesenberry CP, Sorel ME,Mendoza GR, Leong AB. Computerbased models to identify high-risk children with asthma. Am J Respir Crit Care Med 1998; 157(4 Pt 1):1173-1180.
16. Lieu TA, Capra AM, Quesenberry CP, Mendoza GR, Mazar M. Computerbased models to identify high-risk adults with asthma: is the glass half empty of half full? J Asthma 1999; 36:359-370.
17. Schatz M, Cook EF, Joshua A, Petitti D. Risk factors for asthma hospitalizations in a managed care organization: development of a clinical prediction rule. Am J Manag Care 2003; 9:538-547.
18. Schatz M, Nakahiro R, Jones CH, Roth RM, Joshua A, Petitti D. Asthma population management: development and validation of a practical 3-level risk stratification scheme. Am J Manag Care 2004; 10:25-32.
19. Keogh KA, Macarthur C, Parkin PC, et al. Predictors of hospitalization in children with acute asthma. J Pediatr 2001; 139:273-277.
20. Jones R, Lin S, Munsie JP, Radigan M, Hwang SA. Racial/ethnic differences in asthma-related emergency department visits and hospitalizations among childrenwith wheeze in Buffalo,NewYork. J Asthma 2008; 45:916-922.
21. Eisner MD,Katz PP,Yelin EH, Shiboski SC,Blanc PD. Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity. Respir Res. 2001; 2:53-60.
22. Crocker D, Brown C, Moolenaar R, et al. Racial and ethnic disparities in asthma medication usage and health-care utilization. Data From the National Asthma Survey. Chest 2009; 136:1063-1071.
23. Almqvist C, Pershagen G,WickmanM. Low socioeconomic status as a risk factor for asthma, rhinitis and sensitization at 4 years in a birth cohort. Clin Exp Allergy 2005; 35:612-618.
24. Stempel DA, McLaughin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control: a 3-year analysis of patient claims. J Allergy Clin Immunol 2005; 115:935-939.
25. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002. J Allergy Clin Immunol 2002; 110(5 Suppl):S141-S219.
26. Rayens MK, Burkhart PV, Zhang M, et al. Reduction in asthma-related emergency department visits after implementation of a smoke-free law. J Allergy Clin Immunol 2008; 122:537-541, e533.
27. Apter AJ. Advances in adult asthma diagnosis and treatment and health outcomes, education, delivery, and quality in 2008. J Allergy Clin Immunol 2009; 123:35-40.
28. Schatz M, Camargo CA Jr. The relationship of sex to asthma prevalence, health care utilization, and medications in a large managed care organization. Ann Allergy Asthma Immunol 2003; 91:553-558.
29. Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55:566-573.
30. Krasner J. Harvard Pilgrim ranked top health plan in nation. Boston Globe. October 26, 2007.
31. Piecoro LT, Potoski M, Talbert JC, Doherty DE. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res 2001; 36:357-371.
32. Breekveldt-Postma NS, Erkens JA, Aalbers R, van de Ven MJ, Lammers JW, Herings RM. Extent of uncontrolled disease and associated medical costs in severe asthma-a PHARMO study. Curr Med Res Opin 2008; 24:975-983.